Q1 2025 Financial Dashboard

Executive Summary

Alvio Labs delivered its first operational quarter in Q1 2025, with a net loss of €10,966.85. The company is currently in pre-revenue phase, investing primarily in Cost of Goods Sold (€10,350.00) while building operational infrastructure. Operating expenses of €616.85 reflect lean startup operations with essential consulting, software and R&D expenditures.

The balance sheet shows a negative net asset position of €14,416.85, funded primarily through director contributions (€13,993.09 current account + €550.00 loan). Cash position stands at €532.14. At a monthly burn rate of approximately €3,656, this represents roughly 4 days of runway — immediate capital considerations are required.

Critical Alert: The business is currently funded by director capital and is not yet self-sustaining. Revenue generation and/or additional capital injection should be prioritized to extend operational runway.

Net Profit / Loss (Q1 2025)

€-10,966.85

Pre-revenue startup phase

Cost of Goods Sold

€10,350.00

94.4% of total costs

Cash Position

€532.14

~4 days runway

Net Assets

€-14,416.85

Director-funded

OpEx

€616.85

A/P Outstanding

€405.90

Director Current

€13,993.09

Director Loan

€550.00

Total Liabilities

€14,948.99

Burn Rate/Month

€3,656

Expense Breakdown

Cash Position Trend

Liability Composition

Cost of Goods Sold

€10,350.00

Direct product/development costs

Operating Expenses

€616.85

5.6% of total quarterly costs

Net Loss

€-10,966.85

Q1 2025 result (pre-revenue)

Operating Expense Breakdown

Monthly Expense Trend

Quarterly Operating Expense Detail

Account	Q1 2025	% of OpEx	% of Total Costs
Consulting & Accounting	€405.90	65.8%	3.7%
Research & Development	€198.27	32.1%	1.8%
Bank Fees	€10.00	1.6%	0.1%
Office: Software Expenses	€2.68	0.4%	0.0%
Total Operating Expenses	€616.85	100.0%	5.6%

Analyst Note

Operating expenses are tightly controlled at €616.85 for the quarter (€205.62/month average). The bulk of costs (€10,350) are classified as COGS, suggesting product development or service delivery costs. As a pre-revenue entity, every euro in COGS represents unrecovered investment. The consulting/accounting expense (€405.90) indicates professional services engaged — consider whether these are one-time setup costs or ongoing requirements.

Total Assets

€532.14

100% cash (Revolut EUR)

Total Liabilities

€14,948.99

93.6% director funding

Net Assets

€-14,416.85

Accumulated deficit position

Liability Structure

Assets vs Liabilities

Balance Sheet Detail (March 31, 2025)

Assets

Current Assets
Revolut EUR Main	€532.14
Total Assets	€532.14

Liabilities & Equity

Current Liabilities
Accounts Payable	€405.90
Director's Current Account	€13,993.09
Director's Loan Account	€550.00
Total Liabilities	€14,948.99
Net Assets	€-14,416.85

Balance Sheet Context

The liability structure is atypical for an early-stage company: 93.6% of liabilities are director-related (€14,543.09), with only €405.90 in third-party payables. This is favorable from a creditor risk perspective — no external debt pressure. However, the negative net asset position and minimal cash reserves indicate the company needs additional funding or revenue generation to sustain operations beyond immediate term.

Critical Alerts & Required Actions

URGENT

Cash Runway Critical

With €532.14 cash and a monthly burn rate of ~€3,656 (€10,967 / 3 months), runway is approximately 4-5 days. Immediate capital injection from director accounts or external funding is required to avoid operational interruption.

ACTION

Revenue Generation Required

Current model is entirely cost-driven with no revenue line items. The €10,350 in COGS represents product/service development without corresponding sales. Establish go-to-market timeline and first revenue target within 30-60 days.

MONITOR

COGS Efficiency

COGS represents 94.4% of total costs. Monitor unit economics closely once sales commence — current COGS will need to be recovered through gross margin on future revenue. Target 70%+ gross margin to achieve healthy unit economics.

Burn Rate (Monthly)

€3,656

Q1 average

Runway (Days)

~4-5

At current burn

Capital Deployed

€14,543

Director funding

OpEx Efficiency

€206

Per month

Q1 2025 Financial Snapshot

Total Costs Incurred

€10,966.85

Cash Burn %

2056%

Of starting cash

Third-Party Debt

€405.90

Minimal creditor risk

R&D Investment

€198.27

1.8% of total costs